Biswas et al reported that NF-κB is activated more often in ER− human breast tumours compared with ER+ breast tumours and most predominantly in ER− and ErbB2+ breast tumours (Biswas et al, 2004). This evidence concerns the gene NFKB1 and breast neoplasm.